This article discusses key points towards a paradigm shift regarding the role of entrepreneurial education.
Peter Tindemans debates about the recent reorganisation of the DG RTD to reform and improve the STI systems of Member States.
Matias Barberis argues dystopian literature could inspire innovation and policymaking as it links to future thinking and scenario planning.
Sukarma Thareja shares a poem about science innovation in times of COVID19, the vaccine and the horizon of returning to “normal” life.
Krishna Ravi Srinivas gives an update about the initiatives of the Indian Government to fight against the coronavirus covid-19 pandemic.
For the first time, a session on cooperation with Europe, organized with the assistance of the Association of European Businesses: “Russian-European Relations Today and Tomorrow: Challenges and Opportunities for Business” was held on the margins of SPIEF-2019.
From June 6 to June 8, the St. Petersburg International Economic Forum (SPIEF-2019) was held in the northern capital of Russia.
LOFAR (Low Frequency Array) is the world’s largest and most sensitive low frequency radio telescope. It was designed, built, and is now operated by ASTRON, the Netherlands Institute for Radio Astronomy. LOFAR’s reach now spans Europe – from Ireland to Poland, with the newest LOFAR antenna station being delivered to Ventspils University of Applied Sciences in Latvia. Here we propose that LOFAR is a prime example of how state-of-the-art facilities leads to the sharing and building of competencies and innovation: it is one of today’s major success stories of research infrastructures on a European scale.
EuroScientist is off for a summer break!
In the meantime, help us sign and spread the petition to double the EU Budget for Research and Innovation compared to Horizon 2020.
The #DoubleRIEU petition is an initiative from EuroScience and Initiative for Science in Europe.
The term ‘value’ is at the centre of an increasingly explicit debate in the fields of health and healthcare policy. ‘Value’ is understood in many different ways and diverging interests are being mobilised. How are values in biomedical innovation being expressed, represented, materialised and aligned or contested in different areas of biomedicine? How do values embedded in regulation, public health, economic policies, healthcare provision, technology assessment, producers’ strategies, and patient organisation movements shape biomedical innovations? At an ESOF discussion in Toulouse multidisciplinary perspectives on value between panel members and public participants will be explored and possible pathways to common solutions identified that promote socially acceptable biomedical innovation in the European context.
Responsible Research and Innovation (RRI) has become a buzzword in European science in the last few years. Scientists must fill in the RRI section in their European project and sometimes they don’t know what to write there. Others are anxious to have the RRI tag attached to their communication and PR activities. But what RRI really is? Why is it needed? How could science and society benefit from this approach? The strict definition of RRI implies a radical change in the way of conceiving scientific projects from the very beginning, bringing a wide range of stakeholders (from companies to activists, from designers to patients…) in defining the scientific agenda. Are researchers prepared for that? What is the actual level of implementation of RRI in European science? What policies are there in place to facilitate this process?
Two researchers or research laboratories from across the world will be awarded a total of 60,000 euros each, as part of the 2018 Groupe Roullier Innovation Awards. Previous winners have had their work from a broad range of research areas, including plant nutrition, soil science, biocontrol and plant engineering, among others. This is a unique opportunity to get financial support for work which is likely to benefit the sponsor of the competition.